Sarah Satola PhD
Overview
Dr. Satola received her Ph.D. degree in Microbiology from Emory University in 1992. Working under Dr. Charles P. Moran, Jr., she studied the regulation of developmentally controlled promoters in the bacterium, Bacillus subtilis and was the recipient of an NIH training award in Biochemistry, Cellular & Molecular Biology.
Dr. Satola completed her postdoctoral training at Emory University under Dr. Monica M. Farley studying virulence mechanism of Haemophilus influenzae and the role of pili in mucosal attachment and pathogenesis. From 1998-2002.
Dr. Satola was Staff Scientist, Research Service at the Atlanta VA Medical Center where she continued her research on the molecular pathogenesis of Haemophilus influenza.
Dr. Satola is currently an Assistant Professor of Medicine (Infectious Diseases) at Emory University School of Medicine, Assistant Professor of Pathology and Laboratory Medicine and the Director of the Georgia Emerging Infections Program Laboratory.
The laboratory of the Georgia Emerging Infections program focuses on molecular epidemiology of invasive bacterial pathogens of public health importance such as Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, and methicillin-resistant Staphylococcus aureus (MRSA). Current research includes:
1) Molecular epidemiology of colonization and invasive MRSA
2) Evaluating methods for detection of heteroresistant vancomycin intermediate Staphylococcus aureus (hVISA) and characterization of MRSA infections with reduced levels of vancomycin susceptibility
3) Defining the spectrum of genetic variant that cause reduced to non-susceptibility to vancomycin in S. aureus
4) Development of a genetic assay for vancomycin intermediate S. aureus (VISA)
5) Long term impact of PCV7 and PCV13 on Pneumococcal colonization in children
6) Molecular characteristics community-onset MRSA among children
Academic Appointment
- Associate Professor, Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine
- Associate Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine
- Assistant Professor of Medicine, Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine
Education
Degrees
- PhD from Emory University
- BA from Goucher College
Research
Focus
- The laboratory of the Georgia Emerging Infections program focuses on molecular epidemiology of invasive bacterial pathogens of public health importance such as Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, and methicillin-resistant Staphylococcus aureus (MRSA). Current research includes: 1. Genetics and pathogenesis of Haemophilus influenzae 2.Long term impact of PCV7 on Pneumococcal colonization in children 3.Molecular characteristics of community-onset MRSA among Children
Publications
-
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study.
Lancet Infect Dis Volume: 25 Page(s): 574 - 584
05/01/2025 Authors: Shields RK; Abbo LM; Ackley R; Aitken SL; Albrecht B; Babiker A; Burgoon R; Cifuentes R; Claeys KC; Curry BN -
Comparative genomic analysis of emerging non-typeable Haemophilus influenzae (NTHi) causing emerging septic arthritis in Atlanta.
PeerJ Volume: 13 Page(s): e19081
01/01/2025 Authors: Bixler BJ; Royer CJ; Petit Iii RA; Moller AG; Sefton S; Thomas S; Tunali A; Collins LF; Farley MM; Satola SW -
Associations between neighbourhood-level median household income and outpatients' risk of antibiotic non-susceptible uropathogens in a major urban centre, USA.
JAC Antimicrob Resist Volume: 6 Page(s): dlae179
12/01/2024 Authors: Mwansa CML; Babiker A; Satola S; Logan LK; Nadimpalli ML -
Heteroresistance to piperacillin/tazobactam in Klebsiella pneumoniae is mediated by increased copy number of multiple -lactamase genes.
JAC Antimicrob Resist Volume: 6 Page(s): dlae057
04/01/2024 Authors: Babiker A; Lohsen S; Van Riel J; Hjort K; Weiss DS; Andersson DI; Satola S -
Rates of resistance and heteroresistance to newer -lactam/-lactamase inhibitors for carbapenem-resistant Enterobacterales.
JAC Antimicrob Resist Volume: 6 Page(s): dlae048
04/01/2024 Authors: Lin CK; Page A; Lohsen S; Haider AA; Waggoner J; Smith G; Babiker A; Jacob JT; Howard-Anderson J; Satola SW -
The Burden and Impact of Early Post-transplant Multidrug-Resistant Organism Detection Among Renal Transplant Recipients, 2005-2021.
Open Forum Infect Dis Volume: 11 Page(s): ofae060
03/01/2024 Authors: Babiker A; Karadkhele G; Bombin A; Watkins R; Robichaux C; Smith G; Beechar VB; Steed DB; Jacob JT; Read TD -
Evaluation of Asymptomatic Bordetella Carriage in a Convenience Sample of Children and Adolescents in Atlanta, Georgia, United States.
J Pediatric Infect Dis Soc Volume: 13 Page(s): 105 - 109
01/29/2024 Authors: Acosta AM; Simon A; Thomas S; Tunali A; Satola S; Jain S; Farley MM; Tondella ML; Skoff TH -
Discordant antimicrobial susceptibility and polymerase chain reaction (PCR) testing in a Klebsiella pneumoniae isolate with a carbapenemase gene.
Infect Control Hosp Epidemiol Volume: 44 Page(s): 2100 - 2102
12/01/2023 Authors: Witt LS; Page A; Burd EM; Ozturk T; Weiss DS; Ray SM; Satola S; Gottlieb LB -
Management and outcomes of heart transplant candidates with bloodstream infection on temporary mechanical circulatory support.
J Heart Lung Transplant Volume: 42 Page(s): 1501 - 1504
11/01/2023 Authors: Eichenberger EM; Satola S; Gupta D; Daneshmand M; Pouch S -
Candidemia in thoracic solid organ transplant recipients: Characteristics and outcomes relative to matched uninfected and bacteremic thoracic organ transplant recipients.
Clin Transplant Volume: 37 Page(s): e15038
09/01/2023 Authors: Eichenberger EM; Satola S; Neujahr D; Fowler VG; Gupta D; Ford M; Pouch SM